Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the anthrax vaccine market?

The anthrax vaccine market has experienced strong growth in recent years. It will increase from $11.27 billion in 2024 to $11.88 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth is attributed to concerns about biological warfare, military demand, anthrax outbreaks, public health preparedness, and biodefense programs.

What will be the anthrax vaccine market size in the future?

The anthrax vaccine market is projected to grow strongly, reaching $14.5 billion by 2029 at a CAGR of 5.1%. Growth is driven by global security concerns, emerging threats, government procurement initiatives, and pandemic preparedness. Key trends include technological advancements, greater vaccine accessibility in developing countries, next-generation vaccines, increased government stockpiling, and collaborative research efforts.

Get your anthrax vaccine market report here!

https://www.thebusinessresearchcompany.com/report/anthrax-vaccine-global-market-report

What main drivers are fueling expansion in the anthrax vaccine market?

The increasing prevalence of infectious diseases is expected to fuel the growth of the anthrax vaccine market. Infectious diseases, which are caused by microorganisms such as bacteria, viruses, or fungi, are becoming more common due to demographic shifts, urbanization, environmental changes, and altered human behavior. The anthrax vaccine helps protect against anthrax and may be used more broadly in preventing other infectious diseases. Research indicates that zoonotic diseases, which can spread from animals to humans, cause millions of fatalities each year, thus driving the demand for the anthrax vaccine.

What key areas define the segmentation of the global anthrax vaccine market?

The anthrax vaccine market covered in this report is segmented –

1) By Vaccine Type: Cell-Free Protective Antigen (PA) Vaccine, Live Attenuated Vaccine

2) By Application Type: Animal Use, Human Use

3) By Distribution Channel: Hospitals, Pharmacies, Other Distribution Channels

Subsegments:

1) By Cell-Free Protective Antigen (PA) Vaccine: Recombinant Protective Antigen (rPA) Vaccine, Adjuvanted rPA Vaccine

2) By Live Attenuated Vaccine: Live Attenuated Bacillus anthracis Vaccine, Genetically Modified Live Attenuated Vaccine

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15511&type=smp

Who are the dominant players expanding their reach in the anthrax vaccine market?

Major companies operating in the anthrax vaccine market are Merck & Co. Inc., GC Biopharma, Emergent BioSolutions Inc., Indian Immunologicals Limited, Valneva SE, PharmAthene Inc., Porton Biopharma Limited, Pfenex Inc., Choong Ang Vaccine Laboratories Co. Ltd., Colorado Serum Company, Inc., Elusys Therapeutics Inc., SIGA Technologies Inc., Inovio Pharmaceuticals, Botswana Vaccine Institute, JOVAC, Prokarium, Soligenix Inc., Vaxart Inc., DynPort Vaccine Company LLC, VECOL S.A

How are evolving market trends shaping anthrax vaccine Strategies?

In the anthrax vaccine market, companies are focusing on obtaining FDA approvals for their products to ensure safety and efficacy. For example, in July 2023, Emergent BioSolutions received FDA approval for CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909. This approval ensures the vaccine’s safety and effectiveness, helping protect against anthrax exposure.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15511

Which regions are emerging as leaders in the anthrax vaccine market?

North America was the largest region in the anthrax vaccine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthrax vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

DTP Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report

Dog Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

Inactivated Vaccines Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: